Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
ArriVent BioPharma, Inc. (AVBP) had Weighted-Average Shares Outstanding (Basic) of 38.46M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-35.54M |
|
-- |
|
-- |
|
$38.82M |
|
$-38.82M |
|
$3.28M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-35.54M |
|
$-38.82M |
|
$-38.82M |
|
|
Weighted-Average Shares Outstanding (Basic) |
38.46M |
38.46M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$332.90M |
|
-- |
|
$0.27M |
|
$333.17M |
|
$25.95M |
|
-- |
|
-- |
|
$25.95M |
|
$307.22M |
|
$307.22M |
|
$307.22M |
|
42.45M |
|
| Cash Flow Statement Financials | |
$-160.59M |
|
$-71.23M |
|
$203.06M |
|
$74.29M |
|
$45.54M |
|
$-28.75M |
|
$12.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-160.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.57% |
|
-11.57% |
|
-10.67% |
|
-11.57% |
|
$7.24 |
|
$-4.18 |
|
$-4.18 |
|